期刊文献+

肝癌细胞裂解物致敏DC疫苗诱导的肿瘤特异抗瘤效应 被引量:6

The tumor specific anti-tumor effects mounted by hepatoma cell lysates pulsed DC
原文传递
导出
摘要 目的 研究肝癌细胞裂解物致敏的树突状细胞 (DC)疫苗诱导的体内、外抗瘤效应。方法 体外实验 :将肿瘤细胞裂解物致敏的DC与T细胞共培养 ,4d后收获致敏的T细胞 ,观察其对野生型肿瘤细胞的杀伤反应并检测培养液中的IFN γ分泌情况。体内实验 :观察肿瘤细胞裂解物致敏的DC疫苗对小鼠皮下肝癌发生的抑制作用。结果 在效 :靶比分别为 5 0 .0∶1.0、2 5 .0∶1.0、12 .5∶1.0时 ,肝癌细胞裂解物致敏的DC组与DC组诱导的肿瘤杀伤活性分别为 (4 5 .7±3 .2 ) %对 (2 6.5± 2 .5 ) % ;(3 1.0± 2 .7) %对 (14 .3± 3 .3 ) % ;(2 7.8± 1.7) %对 (9.9± 0 .6) % (在各效靶比 ,P <0 .0 1) ,混合细胞培养上清液中IFN γ浓度则为 (2 60 3 .3± 2 60 .0 )ng/L对 (5 0 1.0±5 0 .0 )ng/L。在体内则可有效抑制小鼠皮下肝癌的发生。 Objective To study the anti-tumor effects elicited by hepatoma cell lysates pulsed DC vaccine both in vitro and in vivo.Methods For in vitro study,the sensitized T cells were harvested 4 days after co-culture of tumor cell lysates pulsed DC with naive T cells and used as effectors to observe the cytotoxicity against the wild type tumor cells.The expression levels of IFN-γ in the supernatant of co-culture were detected by ELISA method.For in vivo study,the preventive effects of tumor cell lysates pulsed DC vaccine were evaluated in a murine hepatocellular carcinoma model.Results The tumor lysis ratios (%) in pulsed DC vaccine group were higher than in DC vaccine group (45.7±3.2 vs 26.5±2.5, 31.0±2.7 vs 14.3±3.3,27.8±1.7 vs 9.9±0.6 at ratios of 50.0∶1.0,25.0∶1.0,12.5∶1.0 effector/target),respectively.The IFN-γ (ng/L) expression level in the supernatant in pulsed DC vaccine group (2?603.3±260.0) was also higher than that in DC vaccine group (501.0±50.0).The in vivo growth of tumor could be inhibited effectively by pulsed DC vaccine.Conclusion The hepatoma cell lysates pulsed DC vaccine can induce tumor specific anti-tumor effects.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2003年第9期797-798,共2页 Chinese Journal of Experimental Surgery
基金 国家重点基础研究 (973)项目 (G1 9980 51 2 0 0 ) 国家"九五"科技攻关项目 (96 90 6 0 1 2 0 ) 国家自然科学基金资助项目(39770 82 6)
关键词 肝癌 细胞裂解物致敏 树突状细胞 疫苗诱导 肿瘤特异抗瘤效应 Carcinoma,hepatocellular Dendritic cells IFN-γ
  • 相关文献

参考文献1

二级参考文献12

  • 1Vollmer CM, Eilber FC, Butterfield LH, et al. α-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. Cancer Res, 1999,59:3064-3067.
  • 2Davis HL, Schirmbeck R, Reimann J, et al. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum Gene Ther, 1995,6:1447-1456.
  • 3Geissler M, Tokushige K, Chante CC, et al. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology, 1997,112:1307-1320.
  • 4Kuhober A, Pudollek HP, Reifenberg K, et al. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice. J Immunol, 1996,156:3687-3695.
  • 5Michel ML, Davis HL, Schleef M, et al. DNA-mediated immunization to the hepatitis B surface antigen in mice: Aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA, 1995,92:5307-5311.
  • 6Hsu HC, Wu TT, Sheu JC, et al. Biologic significance of the detection of HBsAg and HBcAg in liver and tumor from 294 HBsAg-positive patients with primary hepatocellular carcinoma. Hepatology, 1989,9:747-750.
  • 7Lu L, McCaslin D, Starzl TE, et al. Mouse bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation, 1995,60:1539-1545.
  • 8Lu L, Rudert WA, Qian S, et al. Growth of donor-derived dendritic cells from the bone marrow of liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med, 1995,182:379-387.
  • 9詹绍康, 金丕焕. 两均数差别的统计意义检验. 见: 金丕焕, 主编. 医用统计方法. 上海: 上海医科大学出版社, 1993. 34-49.
  • 10Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature, 1998,392:245-252.

共引文献5

同被引文献41

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部